Anti-Inflammatory & Antibiotic Eye Drop Franchise in Ahmedabad

Betamethasone + Neomycin Eye Drop Supplier in Mumbai

Ophthalmic Infection & Inflammation Distributor in Delhi

Eye Care Pharma Franchise in Bangalore

Betamethasone + Neomycin Eye Drop Stockist in Hyderabad
Dual-Action Ophthalmic Drop Manufacturer & Exporter in Chandigarh

Home/Products /betamethasone-0-1-w-v-neomycin-0-5-w-v-eye-drop

Betaprol N Eye Drop

Composition : Betamethasone (0.1% w/v) + Neomycin (0.5% w/v) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Betaprol N Eye Drop contains Betamethasone 0.1% w/v + Neomycin 0.5% w/v, a dual-action ophthalmic formulation designed to treat both inflammatory and bacterial eye conditions effectively. Its precise composition ensures safe, fast, and reliable relief.

The drop works by reducing inflammation with Betamethasone and eliminating bacterial infections with Neomycin, alleviating redness, swelling, discharge, and discomfort, while supporting faster recovery and patient comfort.

From a franchise perspective, Betaprol N Eye Drop is a high-demand dual-action ophthalmic product, widely used in eye clinics, hospitals, and diagnostic centers, offering steady sales, repeat orders, and strong prescriber trust.

Adding Betaprol N Eye Drop to your portfolio strengthens the ophthalmic dual-action segment, providing long-term growth, enhanced market credibility, and a competitive edge for franchise partners in the eye care market.

Read More

About the Product

Betaprol N Eye Drop contains Betamethasone 0.1% w/v + Neomycin 0.5% w/v, a dual-action ophthalmic formulation designed to treat both inflammatory and bacterial eye conditions effectively. Its precise composition ensures safe, fast, and reliable relief.

The drop works by reducing inflammation with Betamethasone and eliminating bacterial infections with Neomycin, alleviating redness, swelling, discharge, and discomfort, while supporting faster recovery and patient comfort.

From a franchise perspective, Betaprol N Eye Drop is a high-demand dual-action ophthalmic product, widely used in eye clinics, hospitals, and diagnostic centers, offering steady sales, repeat orders, and strong prescriber trust.

Adding Betaprol N Eye Drop to your portfolio strengthens the ophthalmic dual-action segment, providing long-term growth, enhanced market credibility, and a competitive edge for franchise partners in the eye care market.

Common side effects may include temporary stinging or burning sensation, mild eye irritation, or blurred vision. Rarely, prolonged use may lead to increased intraocular pressure, cataract formation, or secondary eye infections. Allergic reactions to Neomycin may also occur in sensitive individuals.

Betaprol N Eye Drop is indicated for the treatment of inflammatory ocular conditions where there is a risk or presence of bacterial infection, such as uveitis, keratitis, conjunctivitis, or post-surgical eye inflammation. Use should be under strict supervision of an ophthalmologist.

Use Betaprol N Eye Drop strictly under the guidance of an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Do not use for prolonged periods without medical supervision. Discontinue and consult a doctor if severe irritation, vision changes, or signs of infection occur.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation